Unlu Hayrunnisa, Macaron Marie Michele, Ayraler Taner Hande, Kaba Duygu, Akin Sari Burcu, Schneekloth Terry D, Leggio Lorenzo, Abulseoud Osama A
Department of Psychiatry and Psychology, Mayo Clinic Arizona, Phoenix, AZ, United States.
Department of Child and Adolescent Psychiatry, Baskent University School of Medicine Hospital, Ankara, Turkey.
Front Psychiatry. 2023 Sep 22;14:1266424. doi: 10.3389/fpsyt.2023.1266424. eCollection 2023.
We conducted a review of all studies comparing clinical aspects of alcohol withdrawal syndrome (AWS) between men and women.
Five databases (PubMed, Cochrane, EMBASE, Scopus and Clinical Trials) were searched for clinical studies using the keywords "alcohol withdrawal syndrome" or "delirium tremens" limited to "sex" or "gender" or "sex difference" or "gender difference." The search was conducted on May 19, 2023. Two reviewers selected studies including both male and female patients with AWS, and they compared males and females in type of AWS symptoms, clinical course, complications, and treatment outcome.
Thirty-five observational studies were included with a total of 318,730 participants of which 75,346 had AWS. In twenty of the studies, the number of patients presenting with or developing AWS was separated by sex, resulting in a total of 8,159 (12.5%) female patients and a total of 56,928 (87.5%) male patients. Despite inconsistent results, males were more likely than females to develop complicated AWS [delirium tremens (DT) and AW seizures, collective DT in Males vs. females: 1,792 (85.4%) vs. 307 (14.6%), and collective seizures in males vs. females: 294 (78%) vs. 82 (22%)]. The rates of ICU admissions and hospital length of stay did not show sex differences. Although variable across studies, compared to females, males received benzodiazepine treatment at higher frequency and dose. One study reported that the time from first hospitalization for AWS to death was approximately 1.5 years shorter for males and males had higher mortality rate [19.5% (197/1,016)] compared to females [16% (26/163)].
Despite the significant heterogeneity of the studies selected and the lack of a focus on investigating potential sex differences, this review of clinical studies on AWS suggests that men and women exhibit different AWS manifestations. Large-scale studies focusing specifically on investigating sex difference in AWS are needed.
我们对所有比较男性和女性酒精戒断综合征(AWS)临床特征的研究进行了综述。
使用关键词“酒精戒断综合征”或“震颤谵妄”,并限定为“性别”或“sex”或“性别差异”或“sex difference”,在五个数据库(PubMed、Cochrane、EMBASE、Scopus和临床试验)中检索临床研究。检索于2023年5月19日进行。两名评审员选择了包括患有AWS的男性和女性患者的研究,并比较了男性和女性在AWS症状类型、临床病程、并发症和治疗结果方面的差异。
纳入了35项观察性研究,共有318,730名参与者,其中75,346人患有AWS。在20项研究中,出现或发展为AWS的患者数量按性别分开,共有8,159名(12.5%)女性患者和56,928名(87.5%)男性患者。尽管结果不一致,但男性比女性更易发生复杂的AWS[震颤谵妄(DT)和AWS癫痫发作,男性与女性的DT合计:1,792例(85.4%)对307例(14.6%),男性与女性的癫痫发作合计:294例(78%)对82例(22%)]。ICU入院率和住院时间未显示出性别差异。尽管不同研究结果各异,但与女性相比,男性接受苯二氮䓬类药物治疗的频率和剂量更高。一项研究报告称,男性从首次因AWS住院到死亡的时间比女性短约1.5年,且男性的死亡率[19.5%(197/1,016)]高于女性[16%(26/163)]。
尽管所选研究存在显著异质性且缺乏对潜在性别差异的重点研究,但这项关于AWS的临床研究综述表明,男性和女性表现出不同的AWS表现。需要开展专门针对研究AWS性别差异的大规模研究。